Skip to main content

Table 2 Health outcomes of rotavirus versus HPV vaccination among the 72 GAVI-eligible countries (following a single cohort)

From: Comparative evaluation of the potential impact of rotavirus versus hpv vaccination in GAVI-eligible countries: A preliminary analysis focused on the relative disease burden

Health outcome measures

Rotavirus

HPV

Target population (year 2010)

75,761,613

32,453,017

Number vaccinated

53,033,129

22,717,112

Number of lives saved per 1000 vaccinated

5.2

12.6

Deaths averted (r = 0%)

273,855

285,921

   Deaths averted by region (r = 0%) (% of total)

  

AFR D, E

148,541 (54%)

89,524 (31%)

AMR A, B, D

1,808 (1%)

6,651 (2%)

EMR D

30,238 (11%)

12,611 (4%)

EUR B, C

3,257 (1%)

3,554 (1%)

SEAR B, D

85,579 (31%)

161,724 (57%)

WPR B

4,432 (2%)

11,857 (4%)

Years of life saved (r = 0%)

15,740,674

6,030,585

Years of life saved (r = 3%)

7,121,323

1,266,029

DALYs averted (r = 0%, uniform age weight)

15,767,404

6,191,573

DALYs averted (r = 3%, uniform age weight)*

7,146,859

1,304,426

   DALYs averted by region (r = 3%, uniform age-weight) (% of total)

  

AFR D, E

3,748,499 (52%)

436,230 (33%)

AMR A, B, D

50,093 (1%)

34,160 (3%)

EMR D

784,703 (11%)

55,724 (4%)

EUR B, C

90,541 (1%)

21,296 (2%)

SEAR B, D

2,350,198 (33%)

707,996 (54%)

WPR B

122,825 (2%)

49,020 (4%)

DALYs averted (r = 0%, non-uniform age weight)

18,920,531

4,847,082

DALYs averted (r = 3%, non-uniform age weight)

8,121,119

1,148,295

  1. r = discount rate, DALY = Disability-adjusted life year.
  2. * Base-case